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Abstract
In the present work we investigate the chemotactically and proteolytically driven tissue
invasion by cancer cells. The model employed is a system of advection-reaction-diffusion
equations that features the role of the serine protease urokinase-type plasminogen activator.
The analytical and numerical study of this system constitutes a challenge due to the merging,
emerging, and travelling concentrations that the solutions exhibit.
Classical numerical methods applied to this system necessitate very fine discretization
grids to resolve these dynamics in an accurate way. To reduce the computational cost without
sacrificing the accuracy of the solution, we apply adaptive mesh refinement techniques,
in particular h-refinement. Extended numerical experiments exhibit that this approach
provides with a higher order, stable, and robust numerical method for this system. We
elaborate on several mesh refinement criteria and compare the results with the ones in the
literature.
We prove, for a simpler version of this model, L∞ bounds for the solutions, we study
the stability of its conditional steady states, and conclude that it can serve as a test case
for further development of mesh refinement techniques for cancer invasion simulations.
Key words: cancer modelling, chemotaxis, merging and emerging concentrations, finite volume
method, IMEX, adaptive mesh refinement
AMS subject classification: 92B05, 35Q92, 65M08, 65M50
1 Introduction
Cancer is one of the most frequent causes of death worldwide. As reported in [TGE08] by 2020
about 70% of all cancer-related death will occur in developing countries, where the survival rate
is only about 20%-30% due to a late diagnosis. The development of cancer involves different
sub-processes like growth, vascularization, tissue invasion, and metastasis, [KBKR12].
Since the 1950s, the mathematical description of complex biological system has gained increasing
interest and has become a very active research field, e.g. [Nor53, AD54, Fis58]. The growth and
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invasion of cancer was subject of many theoretical studies, concentrating on different aspects
and employing different mathematical approaches; see for example cancer growth [AL87, Pre03,
BCH+13]; cancer cells invasion of the Extracellular Matrix (ECM) [PSNB96, ACN+00, TS02,
FZS+06, GC08, PAG+09, SRLC09, PAS10]; cancer stem cells modelling [GFJ+11, SMC12], to
name but a few.
This is the first in a series of papers where we address a mathematical approach to describe
the invasion of cancer cells into the extracellular matrix and which involve the degeneration of
the adjacent tissue by the cancer cells and their migration into nearby areas. In these works we
model, analyse, and numerically resolve different biological theories that address the pathway
of chemical interactions taking place during the invasion of the cancer cells.
In the current paper, in particular, our primer objective is to lay the foundation and to pro-
pose/present the numerical treatment that we use in our studies. We focus on a model intro-
duced by Chaplain and Lolas in [Lol03, CL05] and further analyzed in [AGL+11, GC06, GC08,
SRLC09, Kol13]. It describes the dynamics of cancer invasion using a deterministic model of
macroscopic quantities. The invasion process is dominated by directed cell movement due to
the gradient of extracellular chemicals (chemotaxis) and due to the gradient in the structure of
the extracellular matrix (haptotaxis) that is mathematically described according to Patlak and
Keller-Segel [Pat53, KS71]. The model includes further the interactions of the cancer cells with
different proteins and diffusion of the cells and the proteins.
Due to the model dynamics, suitable, accurate numerical methods of high order are needed for
the simulations. To this end we employ, at first, a finite-volume method introduced in [KLM14],
augmented with several time integration methods. We notice in one-dimensional experiments
that a large number of grid cells is needed to properly resolve the dynamics, albeit the methods
employed are stable and second order accurate. The corresponding two-dimensional experiments
reveal similar dynamics. Using though a grid as fine as in the one-dimensional case, renders the
computation prohibitively expensive.
Such difficulties are not new in the mathematical literature; there are several examples where
the convergence of a numerical method depends heavily on the size of the discretization cells,
and at the same time, the use of uniformly fine discretization grids is not satisfactory due to
the increased computational cost. In such cases, mesh refinement techniques are often seen as
an alternative numerical treatment. With such methods, one alters the local density of the
discretization grid either by refining the mesh locally. It has been seen, time and again, that
such methods can improve the quality of the numerical solutions, and at the same time reduce
the computational cost, see e.g. [AMS10, KO00, LMS13, Ohl99, PS11, Sfa13]. Therefore, we
investigated the properties of the cancer-invasion-model when employing these mesh refinement
techniques, in particular h-refinement in the form of cell bisection based on properly chosen
estimator functions.
We study analytically a reduced chemotaxis-haptotaxis model with logistic growth, and com-
pare it with the original system in terms of qualitative behaviour of their respective solutions.
Moreover, we investigate the conditional stability of the steady states for particular parameter
ranges and justify the similarities in the transient behaviour of merging, emerging and travelling
concentrations that both systems exhibit numerically. Furthermore we prove L∞ bounds on
the solutions of both systems; allowing hence to use the smaller model and the corresponding
parameter set, as a test case for the development of the mesh refinement techniques for the
cancer invasion models.
The present paper is organized as follows: In Section 2 we describe in more details some impor-
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tant physiological aspects of tumor biology. Based on the biological understanding we explain
in Section 3 the corresponding mathematical model describing tumor proliferation and invasion.
In Sections 5 and 6 we describe the numerical methods, and mesh refinement techniques, which
we have used for the approximations and discuss the results of numerical experiments.
2 Tumor Biology
Tumorgenesis is a multistep process, in which normal cells progressively convert to cancer cells.
This process is associated with various changes in cell physiology common to most of the cancers.
These are, in particular, self-sufficiency in growth signals, insensitivity to inhibitory growth
signals, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis,
tissue invasion and metastasis, and immunoediting [HD02, OM04, TGE08].
Tumor development is directly and indirectly influenced by paracrine as well as autocrine sig-
nals. Such factors include angiogenesis factors, growth factors, chemokines (signaling molecules
originally characterized by their ability to induce chemotaxis), cytokines, hormones, enzymes,
cytolytic factors, and so forth, which may promote or reduce tumor growth [TGE08]. One im-
portant property which distinguished tumor cells from normal cells is their ability to proliferate
infinitely. This is the result of changes in cell death signaling pathways (apoptosis)[KWC72].
Angiogenesis is a next important factor for tumor growth. Growth of blood capillaries into the
tumor is necessary for supply of nutrient and oxygen, and is induced by growth factors, such as
Vascular Endothelial Growth Factor (VEGF). Angiogenesis is also required for metastases and
tissue invasion of the tumor. Metastatic tumors are the cause of about 90% of human cancer
deaths [Spo96]. Spreading of metastases is possible through hematogenous and lymphogeneous
pathways, which guide the metastases to other locations in the body, where they settle (intrava-
sation). Both intravasation and the detachment from the original location (extravasation) is
characterized by changes in the extracellular matrix surrounding the tumor and its interactions
with tumor cells.
Molecular analysis indicates the importance of chemotactic motion in understanding of the out-
growth of tumor cells. As reported in [Zlo06] importance of chemokines in tumor progression was
obtained, e.g, for breast cancer cells that typically metastasized in bone marrow, liver, lymph
nodes and lung. These organs were found to secrete CXCL12, the ligand for the chemokine
receptor CXCR4, which is enriched on breast cancer cells but not in normal breast epithelial
cells [Zlo06].
Chemokines are now known to affect many aspects of tumor development such as angiogenesis
and expression of cytokines, adhesion molecules, and proteases, and support of cancer cell
migration. Thus chemotaxis plays an essential role in the successful outgrowth of tumors to the
preferential organs.
Another important factor that influences tumor growth is the immune system. Physiologically
normal immune system can effectively eliminates highly immunogenic tumor cells. However,
it can also happen that tumor cells with a reduced immunogenicity can develop and further
evase. Thus, the immune system has a selective function for tumor variants. As time evolves
this selection leads to the growth of tumor cells that fail to be controlled by the immune
system. In fact, the interaction between a healthy immune system and tumor cells develops in
three phases: the elimination, the equilibrium and the escape phase. The controlling role of the
immune system, that determines whether and how tumors evolve in time is called immunoediting
process [DOS04].
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Besides evasion of the immune system, chemotaxis towards CXCL12 is a key process also in the
invasion of the Extracellular Matrix (ECM), see e.g. [RCP11]. In more details, organs with high
levels of specific chemokines can direct tumor cells that express the corresponding receptor, to
their site; a result of chemotactic response and ECM invasion. This is the case for the pairs
CXCR4–CXCL12 in bone metastasis of breast and prostate tumors.
Furthermore, the so-called urokinase plasminogen system plays an important role in cancer
progression and metastasis. The proteins of this network on one hand help the tumor cell to
remodel the extracellular matrix, so that it can detach from the original site and re-attach
in another location. In addition, components of the network act as chemokines in order to
guide the direction of tumor migration in this process. In the following, we describe the most
important aspects of the corresponding mathematical model as introduced in [CL05].
The urokinase plasminogen activation system
Migration of (cancer) cells is a regulated process which involves de-attachment and attachment
of the cell to the cellular matrix. The urokinase- plasminogen activation system is involved in
several ways in this complex mechanism. The central role in this system play the urokinase-
plasminogen activator (uPA) and its receptor on the cancer cell surface (uPAR). Although
uPA is a protease and converts the protease plasminogen into its active form plasmin, also
non-catalytical function is involved in the regulation of cancer cell migration.
The protease uPA is secreted by the cancer cell in an inactive form (pro-uPA). This pro-form
binds to uPAR and then can be activated by the protease plasmin. Receptor bound uPA has
several functions: a) it can activate in turn plasmin by cleaving its pro-form plasminogen b)
it enhances the affinity of uPAR to vitronectin [WWR+94] and integrins c) uPA serves as
chemotactic molecule and this action requires binding to uPAR. Activation of plasmin by uPA
can also occur in solution, but is much enhanced if both enzymes are membrane bound.
Vitronectin is a component of the extracellular matrix (ECM) and responsible for the attach-
ment of cells to ECM. Integrins are transmembrane proteins which are responsible for signal
transduction from the outside to the inside of the cell. Vitronectin and uPA/uPAR binds to
integrins and by this are involved in cell signal events.
All three types of function are regulated by the inhibitor PAI-1 (plasminogen activator inhibitor
1). This protein binds to uPA in the soluble and in the membrane-bound form, inhibiting its
proteolytic function. Furthermore, it binds also to vitronectin [SCW+94], and by this inhibits
binding of this cell-adhesion molecule to uPA/uPAR, disrupting cell-ECM-contacts and also
binding to integrins, interfering with cell-signalling. Furthermore, the complex uPAR/uPA/PAI-
1 is removed from the cell surface by endocytosis, triggering further signaling pathways related
to cancer migration. Besides cell signaling pathways related to cell migration, formation of the
uPA/uPAR complexes was shown the increase proliferation of the cell. Chemotaxis induced
by uPA is also inhibited by PAI-1. Furthermore, PAI-1 itself acts as chemotactic molecule and
vitronectin has a similar role as haptotactic molecules, guiding the cell’s movement on the ECM.
The catalytic function of uPA, namely the activation of plasmin, is regarded as essential step
in the cancer-cell’s ability to remodel the ECM.
The ECM is composed of a large number of biochemically and structurally diverse components,
such as proteins, proteoglycans, and glycoproteins. Formation of fibrillar structures by some
of the proteins (eg. collagens, elastin) cause the particular mechano-elastic properties of the
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ECM. These structures are further connected by other proteins such as fibronectin or laminin.
Since intact ECM is a rather tight mesh, offering only small pores for the cell to move through,
cleavage of ECM proteins by the cancer cells greatly enhances motility. However, which ECM-
components can be cleaved by plasmin in vivo is not well investigated, see [DQ12], the best
corrobated examples being laminin and fibronectin; however, MMPs which are activated by
plasmin seem to have multiple roles in the regulation of tumor growth and progression (see
[KPW10] for an overview).
3 Mathematical model
In the literature already several mathematical models for various aspects of cancer invasion have
been presented. The model for the cancer invasion that we investigate in this work is based
on chemotactic/haptotactic movement, diffusion, enzyme interaction and mass conservation. It
was first proposed [CL05, AGL+11], later studied in [AGL+11, GC06, GC08, Kol13, SRLC09],
and will be shortly presented in this section.
In this model, the ECM is represented by the component vitronectin (v). Furthermore, uPAR
is not modeled as a separate entity, but is included via the cell-density. The other components
(uPA, PAI-1, plasmin) are included explicitly, denoted by u, p, m. The differential equations
for the different components are described below.
Cancer cells. The spatio- temporal behavior of cancer cells c is assumed to be determined by
(i) random motion, modeled as diffusion; chemotaxis due to the gradients of (ii) uPA,
and (iii) PAI-1; (iv) haptotaxis due to gradients of the ECM, chemo- and haptotaxis are
modeled according to Keller and Segel [KS71]; (v) proliferation of the cells themselves,
which is assumed to be restricted by the cell number; (vi) increase of proliferation due to
uPA/uPAR compounds.
Consequently, the equation describing the cancer cell dynamics itself reads
∂tc = Dc△c︸ ︷︷ ︸
(i)
− div(χuc∇u︸ ︷︷ ︸
(ii)
+χpc∇p︸ ︷︷ ︸
(iii)
+χv∇v︸ ︷︷ ︸
(iv)
) + µ1c
(
1− c
c0
)
︸ ︷︷ ︸
(v)
+φ1,3 cu︸ ︷︷ ︸
(vi)
. (3.1)
Extracellular matrix. As emphasized in the previous section, the extracellular matrix v is a
static object and thus no transport terms are needed in modeling it. ECM is represented
here as vitronectin, for which the following dynamics are being considered
(i) reconstruction of ECM is mathematically expressed with logistical growth; (ii) degrada-
tion of ECM is assumed to happen proportional to the product of the densities of plasmin
and vitronectin, modeling in a rather global form any kind of degradation of ECM by
plasmin, direct or indirect; (iii) release of v from PAI-1/VN complexes due to competition
of uPA for PAI-1; (iv) release of v from PAI-1/VN complexes due to competition of uPA
for PAI-1.
The equation for the ECM dynamics finally reads
∂tv = µ2v
(
1− v
v0
)
︸ ︷︷ ︸
(i)
− δvm︸︷︷︸
(ii)
+φ2,1 up︸ ︷︷ ︸
(iii)
−φ2,2 vp︸ ︷︷ ︸
(iv)
. (3.2)
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Urokinase plasmin activator. For this component, u, the following processes are taken into ac-
count:
(i) uPA diffuses as chemical; (ii) uPA binding to cancer cell surface via uPAR receptors ;
(iii) complex formation with the inhibitor PAI-1; (iv) secretion of uPA by the cancer cells.
Thus it is assumed that the following equation holds for the behavior of the urokinase
dynamics
∂tu = Du△u︸ ︷︷ ︸
(i)
−φ3,3 cu︸ ︷︷ ︸
(ii)
−φ3,1 pu︸ ︷︷ ︸
(iii)
+ α3c︸︷︷︸
(iv)
. (3.3)
Plasminogen activator inhibitor. For this component, p, a similar set of terms is employed:
(i) diffusion, similar to uPA; (ii) binding to uPA; (iii) binding to vitronectin; (iv) produc-
tion by plasmin.
Hence, the corresponding equation reads
∂tp = Dp△p︸ ︷︷ ︸
(i)
−φ4,1 pu︸ ︷︷ ︸
(ii)
−φ4,2 pv︸ ︷︷ ︸
(iii)
+α4m︸︷︷︸
(iv)
. (3.4)
Plasmin. The ECM degenerating enzyme plasmin m is controlled by the following dynamics
(i) chemical diffusion; (ii) it is activated by uPA/uPAR complexes; (iii) activation of
plasmin is inhibited by PAI-1, which binds to uPA; iv) PAI-1/VN compounds result
indirectly in production of plasmin, since bound PAI-1 does not inhibit plasmin formation
anymore; (v) it is deactivated by plasmin inhibitors.
Thus the plasmin dynamics are modeled as follows
∂tm = Dm△m︸ ︷︷ ︸
(i)
+φ5,3 uc︸ ︷︷ ︸
(ii)
−φ5,1 pu︸ ︷︷ ︸
(iii)
+φ5,2 pv︸ ︷︷ ︸
(iv)
−α5m︸︷︷︸
(v)
. (3.5)
To formulate the model in non-dimensional variables, rescaling takes place using reference length
L = 0.1 cm, a reference diffusion coefficient D = 10−6 cm2s−1, a rescaled time parameter
t = L2D−1, and reference densities C, V , U , P , M of the cancer cells, vitronectin, uPA, PAI-1
and plasmin respectively.
As we only consider dimensionless variables, we keep the former notations for the densities of
cancer cells, ECM, and proteins, and end up with the system

∂tc = Dc∆c − div(χuc∇u+ χpc∇p+ χvc∇v) + φ1,3cu+ µ1c(1− c),
∂tv = −δvm+ φ2,1up− φ2,2vp + µ2v(1− v),
∂tu = Du∆u −φ3,1pu− φ3,3cu+ α3c,
∂tp = Dp∆p −φ4,1pu− φ4,2pv + α4m,
∂tm = Dm∆m −φ5,1pu+ φ5,2pv + φ53uc− α5m.
(3.6)
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To simplify the presentation in the following sections we introduce the short notations
w =


c
v
u
p
m


, D(w) =


Dc∆c
0
Du∆u
Dp∆p
Dm∆m


, A(w) =


div(χuc∇u+ χpc∇p+ χvc∇v)
0
0
0
0


, (3.7)
of the variables, diffusion, advection and reaction vectors
R(w) =


φ13cu+ µ1c(1 − c)
−δvm+ φ21up− φ22vp+ µ2v(1 − v)
−φ31pu− φ33cu+ α3c
−φ41pu− φ42pv + α4m
−φ51pu+ φ52pv + φ53uc− α5m


, (3.8)
respectively. We note that the vectors for advection and diffusion include derivatives of w as
well which we have not included in our notation for brevity. With this notation the system
(3.6) recasts into
wt +A(w) = D(w) +R(w). (3.9)
The parameter set P, cf. e.g. [AGL+11], which we also consider in this work is given by

Dc = 3.5 · 10−4, χu = 3.05 · 10−2, µ1 = 0.25, α3 = 0.215,
Du = 2.5 · 10−3, χp = 3.75 · 10−2, µ2 = 0.15, α4 = 0.5,
Dp = 3.5 · 10−3, χv = 2.85 · 10−2, δ = 8.15, α5 = 0.5,
Dm = 4.91 · 10−3, φ13 = 0, φ21 = 0.75, φ22 = 0.55,
φ31 = 0.75, φ33 = 0.3, φ41 = 0.75, φ42 = 0.55,
φ51 = 0, φ52 = 0.11, φ53 = 0.75,
(3.10)
These parameters were estimated by fitting the numerical results to in-vitro experiments, see
[CL05, Lol03] for details. Although we do not address the parameters in detail, we note that
chemo-, haptotactical sensitivities χp, χu and χv are approximately a factor of hundred times
higher than the coefficient Dc. Thus we expect the motion of the cancer cells to be dominated
by taxis. We further note that the parameter δ = 8.15 is much higher in comparison with the
other parameters used, due to the crucial role of tissue degeneration by plasmin.
4 Analytical properties of a chemotaxis-haptotaxis model with
logistic source
Solutions of the system (3.6) feature heterogeneous spatio-temporal dynamics in the form of
emerging, merging and traveling concentrations. This was observed numerically and examined
by steady state analysis in [AGL+11]. In the latter it is commented that these dynamics are
the results of the destabilization of a single steady state of wt = R(w) by advection.
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To give more details, let wˆ ∈ Rn be a positive steady state of wt = R(w). A small pertubation
w(t, x) = wˆ + εw˜(t, x) evolves according to
w˜t = JR(wˆ)w˜ + JT (wˆ)∆w˜ +O(ε2),
where JR(w) and JT (w) are the Jacobians of the reaction R and the general transport oper-
ator T such that div T (∇w) = D(w) − A(w). We denote by JR(w) = DwR(w), JT (w) =
D∇wT (∇w), respectively.
Assuming periodic boundary conditions on (−M,M)d we write the pertubation w˜ in a Fourier
series representation,
w˜(t, x) =
∑
ν∈Zd
aν(t) exp(iνπM
−1 · x), aν : [0, T ]→ Rn.
The evolution of the coefficient functions is determined by the following system of ordinary
differential equations
a′
ν
(t) = (JR(wˆ)− kJT (wˆ)) aν(t), aν(0) = aν,0, ν ∈ Zd,
where
w˜(0, x) =
∑
ν∈Zd
aν,0 exp(iνπM
−1 · x), k = ‖νπM−1‖22.
Thus we can see, that pertubations due to wave number k grow, if
λk(wˆ) = max {Real {spec (JR(wˆ)− kJT (wˆ))}} > 0;
otherwise they are damped. In the case of parameter set P, there is a range of numbers k with
λk > 0, which vanishes if chemotaxis is neglected (that is if χu = χp = χv = 0).
In order to understand the dynamics of (3.6), such as the merging and emerging phenomena,
and to develop an efficient, problem suited, adaptive numerical scheme, let us first consider the
following chemotaxis-haptotaxis model with the logistic source term{
∂tc = Dc∆c−∇ · (χc∇u) + µc(1− c),
∂tu = Du∆u+ αc− βu.
(4.1)
The system (4.1) provides similar dynamics as (3.6). This has been examined in numerical
experiments in [PH11]. In what follows, we demonstrate that the model (4.1) also obtains
increasing modes of pertubations due to chemotaxis. If we neglect the advection terms in (4.1)
we get a system of ordinary differential equations for w = (c, u)T with steady state wˆ = (1, αβ )
T ,
in which case, the Jacobians of reaction and generalized transport are given by
JR(w) =
(
µ(1− 2c) 0
α −β
)
, JT (w) =
(
Dc −χc
0 Du
)
.
Choosing the parameters
Dc = 5.25 · 10−3, Du = 2.5 · 10−3, χ = 4 · 10−2, µ = 0.1, α = 0.115, β = 0.4,
we obtain a range of wave numbers k with a positive value of λk(wˆ), as it is shown in Figure
4.1. This implies that small pertubations due to chemotaxis can increase in time. Analogous
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Figure 4.1: A plot of λk(wˆ) against k. The amplification factor is positive for a wide range of modes.
behaviour has been obtained for system (3.6) in [AGL+11] and for (4.1) with α = β = 1 in
[PH11].
In [CKWW12, KLM14] the authors studied the so-called saturated chemotaxis model and were
able to show the global existence and uniqueness of a classical solution for the chemotaxis model
of one and two species, respectively. In what follows we analyze the chemotaxis-haptotaxis model
with a logistic source term (4.1), modified to include saturated chemotaxis flux, i.e.
{
∂tc = Dc∆c−∇ · (cQ(χ∇u)) + µc(1− c),
∂tu = Du∆u+ αc− βu,
(4.2)
where Q is given by
Q(χ∇u) =


χ∇u, if χ|∇u| ≤ S,(
χ|∇u| − S√
1 + (χ|∇u| − S)2 + S
)
∇u
|∇u| , otherwise,
(4.3)
for a positive constant S. The function Q limits the flux by ‖Q(χ∇u)‖ < S + 1 = C.
Theorem 4.1. We consider (4.2) on a compact set Ω ⊂ Rd with a Lipschitz continuous bound-
ary ∂Ω with the outer normal n and the boundary conditions
∂c
∂n
=
∂u
∂n
= 0, x ∈ ∂Ω, t > 0. (4.4)
Let (c(x, t), u(x, t)) be a positive classical solution with bounded non-negative initial data. Then
the following estimates hold,
c(x, t) ≤ ˜˜Cmax
{
‖co‖L∞(Ω), ‖c0‖L1(Ω) +
T µ|Ω|
4
}
, (4.5)
u(x, t) ≤ ‖u0‖L∞(Ω) +
˜˜Cα
β
max
{
‖co‖L∞(Ω), ‖c0‖L1(Ω) +
T µ|Ω|
4
}
, (4.6)
for all x ∈ Ω¯ and t ∈ [0, T ], where
˜˜C = C˜
(
1 +
2Dcµ
C2
)2(
1 +
√
C2 + 2µDc
Dc
)2d
, (4.7)
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and C˜ depends on Ω only.
Proof. We follow [KLM14] and start by multiplying the first equation of (4.2) by cs−1 for s ≥ 2.
Integration by parts, the chain rule, the bound on Q as well as Young’s inequality yield,
1
s
d
dt
∫
Ω
cs dx = −Dc
∫
Ω
∇c · ∇(cs−1) dx+
∫
Ω
cQ(χ∇u) · ∇(cs−1) dx+ µ
∫
Ω
cs(1− c) dx
≤ −4Dc(s− 1)
s2
∫
Ω
|∇(c s2 )|2 dx+ 2C(s− 1)
s
∫
Ω
c
s
2 |∇(c s2 )| dx+ µ
∫
Ω
cs dx
≤ −4Dc(s− 1)
s2
‖∇(c s2 )‖2L2(Ω) +
2C(1− s)
s
∫
Ω
1
2
(
2Dc
Cs
|∇(c s2 )|+ Cs
2Dc
cs
)
dx+ µ
∫
Ω
cs dx
≤ −2Dc(s− 1)
s2
‖∇(c s2 )‖2L2(Ω) +
C2(s− 1) + 2Dcµ
2Dc
∫
Ω
cs dx.
The last integral is estimated using the interpolation inequality,
‖ω‖2L2(Ω) ≤ ε‖∇ω‖2L2(Ω) +K(1 + ε−
d
2 )‖ω‖2L1(Ω), (4.8)
for a constant K depending only on the domain Ω and a chosen ε [LSU68]. We choose ε such
that
C2(s− 1) + 2Dcµ
2Dc
=
2Dc(s− 1)
s2ε
− C
2(s − 1) + 2Dcµ
2Dc
⇒ ε = 2D
2
c (s− 1)
C2s2(s− 1) + 2Dcµs2 > 0,
and thus get
C2(s− 1) + 2Dcµ
2Dc
∫
Ω
cs dx =
(
2Dc(s− 1)
s2ε
− C
2(s− 1) + 2Dcµ
2Dc
)∫
Ω
cs dx
≤ 2Dc(s− 1)
s2
‖∇(c s2 )‖2L2(Ω) +
2Dc(s− 1)K(1 + ε− d2 )
s2ε
‖c s2 ‖2L1(Ω)
− C
2(s − 1) + 2Dcµ
2Dc
∫
Ω
cs dx.
Hence the dependence on∇(c s2 ) in the above estimates vanishes and using ε− 12 ≤ s
√
C2 + 2µDc/Dc,
we get
d
dt
∫
Ω
cs dx+
sC2(s− 1) + 2sDcµ
2Dc
∫
Ω
cs dx ≤
Ks
(
1 +
(
s
√
C2+2µDc
Dc
)d)
(C2(s− 1) + 2Dcµ)
Dc
(∫
Ω
c
s
2 dx
)2
.
Next, we multiply by the integrating factor eκt, κ = (sC2(s − 1) + 2sDcµ)/2Dc, and obtain
after integrating over [0, t], 0 < t ≤ T and eliminating the integrating factor
∫
Ω
cs(x, t) dx ≤
∫
Ω
cs0 dx+ 2K
(
1 +
2Dcµ
C2(s− 1)
)(
1 +
s
√
C2 + 2µDc
Dc
)d
sup
0≤t≤T
(∫
Ω
c
s
2 dx
)2
(4.9)
Now, the function
M(s) = max
{
‖c0‖L∞(Ω), sup
0≤t≤T
(∫
Ω
c
s
2 dx
) 1
s
}
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satisfies the inequality
M(s) ≤

K˜ (1 + 2Dcµ
C2(s − 1)
)(
1 +
s
√
C2 + 2µDc
Dc
)d
1
s
M(s/2).
Choosing the sequence s = 2k, k ∈ N, and dissolving the recursion by estimating the value of
the monotonously increasing infinite product,
∞∏
k=1
(
1 + 2kC
) d
2k ≤ (2 + 2C)2d,
we get
M(2k) ≤ C˜
(
1 +
2Dcµ
C2
)2(
1 +
√
C2 + 2µDc
Dc
)2d
M(1),
where C˜ = 2max{K˜, K˜2} depends on Ω only. Taking the limit k →∞, we end up with
‖c(·, t)‖L∞(Ω) ≤ C˜
(
1 +
2Dcµ
C2
)2(
1 +
√
C2 + 2µDc
Dc
)2d
M(1) = ˜˜CM(1). (4.10)
We further consider the mass of the component c by integrating the the first equation of (4.2)
and obtain applying Gauss’s theorem and using the non-negativity of c,
d
dt
∫
Ω
c dx = µ
∫
Ω
c(1 − c) dx ≤ µ
∫
Ω
1
4
dx =
µ|Ω|
4
,
since c(1− c) ≤ 1/4 for any c ≥ 0. Therefore we have
M(1) = max
{
‖co‖L∞(Ω), ‖c0‖L1(Ω) +
T µ|Ω|
4
}
.
Together with (4.10) the estimation for c follows.
Because of the maximum principle of heat equation, the solution of the following initial value
problem, 

dω
dt
= −βω + α ˜˜CM(1),
ω(0) = ‖u0‖L∞(Ω),
is an upper bound for u. Hence we can estimate
0 ≤ u(x, t) ≤ ω(t) = e−βt‖u0‖L∞(Ω) + (1− e−βt)
α ˜˜C
β
M(1) ≤ e−βt‖u0‖L∞(Ω) +
α ˜˜C
β
M(1),
which proves the L∞(Ω) bound of the density u.
Remark 4.1. Existence, uniqueness and non-negativity of a classical solution for system (4.1)
with homogeneous Neumann boundary conditions and non-negative initial data c0, u0 ≥ 0 was
shown in [Wrz04, Tao09]. Hence, for a sufficiently large S in (4.3) and non-negative initial
conditions we can assume that the conditions of Theorem 4.1 hold.
Remark 4.2. Additionally, in [MCP10], the authors studied another simplified cancer invasion
model that includes also the degradation of the ECM. They employ nonlinear change of variables
and comparison principles to prove existence, uniqueness, positivity, and boundedness of the
solutions.
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5 Numerical Methods
We perform numerical simulations on a computational domain Ω, which is either an interval
in 1D or a rectangular domain in 2D subdivided into a finite number of computational non
overlapping cells
Ω =
N⋃
i=1
Ci.
In the one-dimensional case on an interval domain Ω = (a, b), the cell interfaces are given by
a = x1/2, xi+1/2 = xi−1/2 + hi, xN = b,
for given cell sizes hi > 0 satisfying
∑N
i=1 hi = b− a. Thus cell centers and cells are defined by
xi =
xi+1/2 − xi−1/2
2
, Ci =
{
xi + λhi, λ ∈
[
−1
2
,
1
2
)}
i = 1, . . . , N.
We will be employing mesh adaptation and although our grid refinement techniques can be
adapted to general two dimensional meshes, we only consider rectangular domains Ω = (a, b)×
(a, b) with uniform quadrilateral cells in this work. Consequently we employ constant grid sizes
h = (h(1), h(2))T , h(1) =
b− a
L
, h(2) =
b− a
M
, N = LM, L,M ∈ N.
This way, cell centers are given by
x1,1 = e1(a+
h(1)
2
) + e2(a+
h(2)
2
),
xi,j = x1,1 + e1(i− 1)h(1) + e2(j − 1)h(2), i = 1, . . . , L, j = 1, . . . ,M,
where e1, e2 are the unit vectors in the spatial directions x1 and x2, respectively. Computational
cells for i = 1, . . . , L, j = 1, . . . ,M are given by
Ci,j =
{
xi,j +
[
λ1 h
(1)
λ2 h
(2)
]
, λ1, λ2 ∈
[
−1
2
,
1
2
)}
.
Moreover, we introduce a single index notation, for cells and cell centers using lexicographical
indexing, i.e.
Ci,j −→ Ci+(j−1)L, xi,j −→ xi+(j−1)L, i = 1, . . . , L, j = 1, . . . ,M,
and inversely,
Ck −→ Ck−[ k−1
L
]L,[ k−1
L
]+1, xk −→ xk−[ k−1
L
]L,[ k−1
L
]+1, k = 1, . . . , LM,
where [ ] is the Gauss floor function.
Let moreover Ck±el denote the neighbouring cell of Ck in positive(negative) el direction (l =
1, 2), i.e., for k = 1, . . . ML we define
Ck±e1 =Ck−[ k−1
L
]L±1,[ k−1
L
]+1, where k 6= 0, 1 modL, respectively (±),
Ck±e2 =Ck−[ k−1
L
]L,[ k−1
L
]+1±1, for k ≤ L(M − 1), k ≥ L+ 1, respectively (±).
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Space discretization. We discretize the system (3.6) with a finite volume method, and
approximate a solution with piecewise constant functions
wi(t) ≈ 1
vol(Ci)
∫
Ci
w(x, t) dx, (5.1)
on every cell. In the following we present discretization of the advection, reaction, and diffusion
operators,
Di(wh(t)) ≈ 1
vol(Ci)
∫
Ci
D(w(x, t)) dx, Ai(wh(t)) ≈ −1
vol(Ci)
∫
Ci
A(w(x, t)) dx,
Ri(wh(t)) ≈ 1
vol(Ci)
∫
Ci
R(w(x, t)) dx,
where wh(·) = {wi(·)}Ni=1. We discretize the reaction term by evaluating the reaction operator
Ri(wh(t)) = R(wi(t)).
Concerning diffusion in dimension 1, we use second order three-point central differences when
the grid is uniform and second order five point central differences when the grid is non-uniform
with hi = |Ci|. In the latter case the discretization of the diffusion operator reads
Di(wh(t)) = D
(
α
(−2)
i wi−2(t) + α
(−1)
i wi−1(t) + α
(0)
i wi(t) + α
(+1)
i wi+1(t) + α
(+2)
i wi+2(t)
)
,
(5.2)
where D is a diagonal matrix with the vector
(
Dc 0 Du Dp Dm
)
on the diagonal, and the
coefficients α
(−2)
i , . . . , α
(+2)
i , σi, are chosen such that we get a second order approximation of
the second derivative, i.e.
α
(−2)
i =− 8
(hi−1 − hi+1)
(hi−2 + 2hi−1 + 2hi + 2hi+1 + hi+2)σi
,
α
(−1)
i =8
hi−1(4hi−1 + 4hi−2 + 2hi − 4hi+1 − 2hi+2) + 3h2i+1
(hi + hi−1)(hi−1 + 2hi + hi+1)σi
+ 8
h2i+2 + 4hi+1hi+2 + hihi+2 + hi−2(hi−2 − 2hi+1 − hi+2 + hi)
(hi + hi−1)(hi−1 + 2hi + hi+1)σi
,
α
(+1)
i =8
hi+1(4hi+1 + 4hi+2 + 2hi − 4hi−1 − 2hi−2) + 3h2i−1
(hi + hi+1)(hi−1 + 2hi + hi+1)σi
+ 8
h2i−2 + 4hi−1hi−2 + hihi−2 + hi+2(hi+2 − 2hi−1 − hi−2 + hi)
(hi + hi+1)(hi−1 + 2hi + hi+1)σi
,
α
(0)
i =− (α(−1)i + α(+1)i ),
α
(+2)
i =− α(−2)i ,
σi =h
2
i−2 + h
2
i+2 + 2(h
2
i−1 + h
2
i+1) + 3(hi−1hi−2 + hi+1hi+2)
+ hi(hi+1 + hi−1 + hi+2 + hi−2)− hi−2(hi+1 + hi+2)− hi−1(hi+1 + hi+2),
The description (5.2) reduces to the common three-point central differences if the grid is uniform
around Ci.
In this work we discretize the advection terms following the guidelines of [KLM14]. The discrete
advection operator in the conservative formulation reads
Ai(wh(t)) = −
d∑
j=1
1
hi
(
Hi+ej/2(wh(t)) −Hi−ej/2(wh(t)) 0 0 0 0
)T
, (5.3)
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where d ∈ {1, 2} is the dimension of the domain. The numerical fluxes Hi+ej/2, cf. (5.5),
are used to approximate the chemotaxis fluxes between the cells Ci and Ci+ej . They are given
by products of approximated characteristic velocities Pi+ej/2 and suitable approximations of
gradients of u, v and p, denoted here by s
(j)
i . To describe Hi+ej/2 we need to define Pi+ej/2
and s
(j)
i . For the approximation of characteristic velocities on the cell interfaces we calculate
approximations of the form
Pi+ej/2(wh(t)) = χuLi+ej/2(uh(t)) + χvLi+ej/2(vh(t)) + χpLi+ej/2(ph(t)),
where Ldiffi+ej/2 represents central difference approximations of the first derivative. Since, 2nd
order approximations cannot be obtained by a three point stencil on non-uniform grids, we
apply a four point finite difference approximation centered around the interface, i.e.
Li+1/2(uh) = β
(−1.5)
i+1/2 ui−1 + β
(−0.5)
i+1/2 ui + β
(+0.5)
i+1/2 ui+1 + β
(+1.5)
i+1/2 ui+2,
where the coefficients are chosen such that we have a third order accurate approximation of the
first derivative,
β
(−1.5)
i+1/2 =
hi+1(6hi − 4hi+1 − 2hi+2) + 2hihi+2
(hi + hi−1)(hi−1 + 2hi + hi+1)(hi−1 + 2hi + 2hi+1 + hi+2)
,
β
(−0.5)
i+1/2 = −
hi+1(12hi + 6hi−1 − 2hi+2 − 4hi+1) + hi+2(2hi−1 + 4hi)
(hi−1 + hi)(hi + hi+1)(hi + 2hi+1 + hi+2)
,
β
(+0.5)
i+1/2 =
hi(12hi+1 + 6hi+2 − 2hi−1 − 4hi) + hi−1(2hi+2 + 4hi+1)
(hi+1 + hi+2)(hi + hi+1)(hi−1 + 2hi + hi+1)
,
β
(+1.5)
i+1/2
= − hi(6hi+1 − 4hi − 2hi−1) + 2hi+1hi−1
(hi+1 + hi+2)(hi + 2hi+1 + hi+2)(hi−1 + 2hi + 2hi+1 + hi+2)
.
In order to approximate the gradient of c, we apply the MC limiter [VL77]. On the uniform
grid it reads
s
(j)
i (ch) = minmod
(
2
ci − ci−ej
h
,
ci+ej − ci−ej
2h
, 2
ci+ej − ci
h
)
.
In the case of non-unform grids in one dimension we obtain
si(ch) = minmod
(
4
ci − ci−1
κi−1
,
−2κici−1
κi−1(κi−1 + κi)
+
2(κ2i − κ2i−1)ci
κi−1κi(κi−1 + κi)
+
2κi−1ci+1
κi(κi−1 + κi)
, 4
ci+1 − ci
κi
)
,
where κi = hi + hi+1. The minmod operator is given by
minmod(v1, . . . , vn) =


max{v1, . . . , vn}, if vk < 0, k = 1, . . . , n,
min{v1, . . . , vn}, if vk > 0, k = 1, . . . , n,
0, otherwise.
(5.4)
The numerical fluxes are based on the upwinding approach and are given as follows
Hi+ej/2(wh) =


Pi+ej/2(wh)
(
ci +
h
(j)
i
2
s
(j)
i (ch)
)
, if Pi+ej/2(ch) ≥ 0,
Pi+ej/2(wh)
(
ci+ej −
h
(j)
i+1
2
s
(j)
i+ej
(ch)
)
, if Pi+ej/2(wh) < 0.
(5.5)
After space discretization, we end up with the following system of ordinary differential equations
∂twh −A(wh) = R(wh) +D(wh). (5.6)
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Time discretization. The numerical approximations of the solution of (5.6) at discrete points
in time tn wil be denoted w
n
h.
The discretization of the taxis-terms dictates a limit on the time step τn = tn+1 − tn according
to the CFL condition
max
i,j
τn
Pi+ej (wnh
hi
= CFL ≤ 1. (5.7)
We have compared several numerical methods to approximate (5.6). They are shortly described
in the following part.
EXPLICIT: The first order forward Euler time integration
wn+1h = w
n
h + τn(A(wnh) +R(wnh) +D(wnh)).
This is the only explicit method, we apply. It requires small time steps for stability reasons
due to the explicit discretization of diffusion. Indeed, τn = O(maxi h2i ).
CND: A Crank-Nicolson type method with
wn+1h −
τn
2
D(wn+1h ) = wnh + τn
(
1
2
D(wnh) +R(wnh) +A(wnh)
)
.
Since we approximate the diffusion term implicitly, we can choose time steps according to
the CFL condition (5.7) alone.
ROSENBROCK: A general s-stage linearly implicit method or Rosenbrock method takes the
form:

wn+1h = w
n
h + τn
s∑
j=1
bjkj ,
(Id− aj,jτn J)kj = g(wnh + τn
j−1∑
ν=1
(aj,ν + γj,ν)kν)− τnJ
j−1∑
ν=1
γj,νkν , j = 1, . . . , s.
(5.8)
for given lower triangular matrices A = (ai,j)
s
i,j=1, Γ = (γi,j)
s
i,j=1, a vector b and
g(wh) = A(wnh) +R(wnh) +D(wnh).
If A, b satisfy specific algebraic conditions, then high order of consistency can be reached
with these methods. Stability properties can be achieved by selecting reasonable values
for the parameter matrix Γ and a suitable approximation J of ∂∂wh (g(wh) [GC06]. We
choose J = ddwh (R(wnh) +D(wnh)) since we assume the taxis discretization to be stable in
explicit methods.
ROS2: An L-stable, second order consistent two stage Rosenbrock method (s = 2), which has
already been used for applications in reaction-diffusion-taxis systems in [GV02]. It is given
by the coefficients
A =
(
1−
√
2
2 0√
2− 1 1−
√
2
2
)
, Γ =
(
0 0
2−√2 0
)
, b =
(
1
2
1
2
)T
. (5.9)
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0 0
1
2
1
4
1
4
1 13
1
3
1
3
1 13
1
3
1
3
Table 5.1: Butcher tableau for the simplified TR-BDF2 method.
ROS3: An L-stable [HV03] third order Rosenbrock method (s = 3) with coefficients
A =


a 0 0
0.5 a 0
0.5 0.5 a

 , γ2,1 = −(3a+ γ3,1 + γ32),
a = 1− 1
2
√
2 cos(θ) +
1
2
√
6 sin(θ), γ3,2 =
1
2
− 3a,
b =
(
1
3
1
3
1
3
)T
, γ3,1 = − 1
1 + 2γ3,2
(
6a3 − 12a2 + 6(1 + γ3,2)a+ 2γ23,2 −
1
2
)
,
θ =
1
3
arctan
(√
2
4
)
.
ROS3-ATC: A ROS3 method with adaptive time step control.
STRANG: A second order splitting approach. Let ΞF(τ)y be a numerically approximated
solution of the initial value problem
∂twh = F(wh), wh(0) = y,
at t = τ , for any operator introduced before, F ∈ {D, R, A}. The Strang-splitting
method yields
wn+1h = ΞT
(τn
2
)
ΞD
(τn
2
)
ΞR(τn) ΞD
(τn
2
)
ΞT
(τn
2
)
wnh. (5.10)
This method is known to be second order in time, if the methods used to compute ΞF (τn),
are at least second order. We choose the fourth order Runge-Kutta method [HNW93] for
the reaction- and taxis-step and the TR-BDF2 method (modified trapezoidal rule with
the second order backward differential formula) for the diffusion-terms. The TR-BDF2
can be written as an imlicit Runge-Kutta method, coefficients can be found in Table 5.1.
STRANG-CND and STRANG-IR: Two variants of the STRANG method: STRANG-CND
uses the Crank-Nicolson method for the diffusion term instead of TR-BDF2 and STRANG-
IR employs the linearly implicit second order method ROS2 for the reaction term instead
of the explicit Runge-Kutta method.
IMEX2 and IMEX3: Second and third order implicit-explicit methods following [PR05]. We
consider a splitting of the ordinary differential equation into an implicit part I and an
explicit part E ,
g(wh) = A(wnh) +R(wnh) +D(wnh) = I(wh) + E(wh),
where I = D and E = A+R, and apply an explicit Runge-Kutta method for the explicit
part and a coupled diagonally implicit Runge-Kutta-method to the implicit part resulting
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0 0 0
1
2
1
2 0
0 1
0 0 0
1
2 0
1
2
0 1
Table 5.2: Tableau for the IMEX-Midpoint scheme (IMEX2). Coefficients A¯, b¯, c¯ for the explicit
scheme on the left and A, b, c for the diagonally implicit scheme on the right, respectively.
0
1767732205903
2027836641118
1767732205903
2027836641118
3
5
5535828885825
10492691773637
788022342437
10882634858940
1 648598928062916251701735622 −42462668470899704473918619 1075544844929210357097424841
1471266399579
7840856788654 −44824441678587529755066697 1126623926642811593286722821 17677322059034055673282236
0 0
1767732205903
2027836641118
1767732205903
4055673282236
1767732205903
4055673282236
3
5
2746238789719
10658868560708 − 6401674452376845629431997 17677322059034055673282236
1 14712663995797840856788654 −44824441678587529755066697 1126623926642811593286722821 17677322059034055673282236
1471266399579
7840856788654 −44824441678587529755066697 1126623926642811593286722821 17677322059034055673282236
Table 5.3: Tableaux for the explicit (first tableau) and the implicit part (second tableau) of the third
order IMEX-Runge-Kutta scheme (IMEX3).
in an implicit-explicit (IMEX) scheme. A general s-stage scheme reads

Ej = E(Wj), i = 1, . . . , s,
Ij = I(Wj), i = 1, . . . , s,
W∗i = w
n
h + τn
i−2∑
j=1
a¯i,jEj + τn a¯i,i−1Ei−1, i = 1, . . . , s,
Wi =W
∗
i + τn
i−1∑
j=1
ai,jIj + τnai,iIi, i = 1, . . . , s,
wn+1h = w
n
h + τn
s∑
i=1
b¯iEi + τn
s∑
i=1
biIi,
(5.11)
where the explicit scheme is given by b¯, A¯ and the diagonally implicit scheme by b, A.
We concentrate on two particular schemes. The first one is the IMEX-Midpoint scheme.
Though it only uses one implicit stage for the diffusion term, it is second order accurate in
time [PR05]. This makes it less expensive than the Strang-splitting. Further, we consider
a third order scheme constructed in such a way that it fulfills several stability conditions,
e.g. A- and L- stability [KC03]. Coefficients for both methods can be found in Tables 5.2
and 5.3.
IMEX3-ATC: Third order IMEX method with adaptive time step control. This method is
applied in two variants: IMEX3-ATC-UPWIND1 uses first order upwind fluxes (s
(j)
i (ch) =
0 in (5.5)). IMEX3-ATC-IR treats reaction terms implicitly and uses I = D +R.
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Adaptivity in time. Adaptive time step control is done conventionally by employing an
additional lower order scheme in order to calculate a local error estimate
ǫn = ‖wn+1h −wn+1, lowh ‖∞. (5.12)
The approximation wn+1h is accepted if
ǫn < ǫ
tol
n = max{10−6, 10−6 ‖wnh‖1}, (5.13)
otherwise the same time step is repeated for a smaller value of τn which we get by multiplying
the old value by 0.9
3
√
etoln
en
.
We consider adaptive time step control for the third order linearly implicit scheme and the
third order IMEX-Runge-Kutta scheme. Both of them are third order methods and feature
an embedded method of second order. Hence, lower order approximations (wn+1, lowh ) can be
obtained without much additional computational costs. Weights β which replace the regular
weights b in the lower order embedded schemes are given by
β¯ = β =
(
2756255671327
12835298489170 −1077155257357522201958757719 924758926504710645013368117 21932090470915459859503100
)T
,
for the IMEX3 scheme, and by
β =
(
1
2
1
2 0
)T
,
for the ROS3 scheme.
Adaptivity in space. We describe the adaptive mesh refinement we use in the case d = 1.
Mesh cells now depend on time as well
Ω =
Nn⋃
i=1
Cni , |Cni | = hni .
We consider the h-refinement method for the refinement of the mesh and proceed as follows,
see also [KO00, Ohl99, PS11]. We prescribe a monitor function, that depends on the numerical
solution, and we evaluate it on every cell i, i.e. Mi(w
n
h). The monitor function will be compared
against two properly chosen coarsening/refinement thresholds Ccoa < Cref. We also assume a
uniform initial grid and set Lni to be the level of refinement of the cell i (zero for the initial
grid). The refinement/ coarsening strategies read as follows
Refinement. If Mi(w
n
h) > Cref the cell is marked for refinement. If the cell is of refinement level
k it is bisected into two isodynamous daughter cells of k + 1 level of refinement. Then
approximate values of the monitor function, using the mother cell and the neighbouring
cells, are computed on every daughter cell. The refinement process is repeated nref times.
Coarsening. If Mi(w
n
h) < Ccoa the cell is marked for coarsening, and if both daughter cells
of the same mother cell are marked for coarsening, they merge into a single cell. The
approximate value of the monitor function on the mother cell is computed by of the
daughter cells’ monitor function. The coarsening process is repeated ncoar times.
We also prescribe a maximal refinement level Lmax.
The monitor functions that we consider in this work are the following
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1. The discrete gradient of c:
Mi(wh) = max
{∣∣∣∣2 ci+1 − cihi+1 + hi
∣∣∣∣ ,
∣∣∣∣2 ci − ci−1hi + hi−1
∣∣∣∣
}
. (5.14)
2. Local approximations of the discretization errors of characteristic velocities:
Mi(wh) = max
{∣∣∣Pi−1/2 − P lowi+1/2∣∣∣ , ∣∣∣Pi+1/2 − P lowi+1/2∣∣∣} , (5.15)
where the lower order approximations of the characteristic velocities P lowi+1/2 are calculated
using two point approximations of the first derivative.
6 Numerical Experiments
We present results of numerical simulations∗and compare the performance of the methods we
introduced previously, and demonstrate the capability of h-refinement.
In order to illustrate the dynamics of the system (3.6), and to compare different time integration
techniques we present simulation results, for benchmark problems similar to those in [AGL+11].
Therefore, we first consider the system (3.6) on a one-dimensional interval Ω together with
homogeneous Neumann boundary conditions.
6.1 Experiment I
The parameters are chosen according to the parameter set P (3.10). The following initial
conditions are assumed:

c0(x) = exp
(−x2
ε
)
,
v0(x) = 1− 1
2
exp
(−x2
ε
)
,
u0(x) =
1
2
exp
(−x2
ε
)
,
p0(x) =
1
20
exp
(−x2
ε
)
,
m0(x) = 0,
, x ∈ (0, 10), (6.1)
where ε = 5 · 10−3. The initial conditions can be interpreted as an accumulation of cancer cells
c, which start their invasion from the left boundary of the domain. The extracellular matrix v
is mostly intact, except for the location of the cancer cell accumulation. Activation of plasmin
m has not taken place up to t = 0, but urokinase u and a smaller amount of urokinase inhibitor
type 1, p, is already on the spot everywhere, where cancer cells are located.
Since we have observed a reliable grid convergence with the IMEX3 time integration method,
we chose this method to compute reference solutions.
Figure 6.1 shows the computed time evolution on the domain Ω = (0, 10). We can see a cluster
of cancer cells, which travels to the right side of the domain, degenerating the ECM. At areas,
∗All the numerical experiments were conducted using MATLAB.
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where vitronectin is already degenerated to a small amount, new clusters, which take the form
of peaks in the cancer cell densities, emerge. This can already be seen at t = 25. The number
of these peaks as well as their heights in c vary in time. Clusters not only emerge, but they
also move and merge. After approximately nine days of biological time (t = 75) almost half of
the domain is invaded by the cancer cells and even when the entire domain is invaded, cancer
cell density exhibits a dynamically heterogeneous spatio-temporal behavior, which can be seen
by comparison at t = 300 and t = 500. The enzymes of the uPA-system, which regulate the
process of invasion, do not develop clusters and take densities between 0 and 1 all over the
period t ∈ [0, 500]. The inhibitor PAI-1 density stays smooth mostly, while uPA and plasmin
develop spiky solutions, as they are more directly influenced by the cancer cells. Due to its
accuracy and relatively low computational costs, we chose the IMEX3 method as a favorite
method, to compute the solutions.
In order to compare different time integration methods, we consider the narrowed domain (0, 5)
and the final time T = 60. We will study how the methods, described in the previous section,
perform in this case. For comparison reasons, we consider a fixed Courant number of CFL=0.49
for every method. The influence of different Courant numbers is studied later, cf. Figure 6.5.
Since the exact solution is not known, we compute a reference solution wref on a grid with
50 000 uniform cells Crefi , i = 1, . . . , 50 000. We are only interested in a solution at time T
and thus we drop the time index and denote by wrefi the reference solution at T = 60 on cell
Crefi , its interpolant by w
ref and its first component, the cancer cell density, by cref. In order to
compare the accuracy of the introduced methods in space, we compute the discrete L1-errors
of the cancer cell densities:
E(N) := |cref − cN |L1disc(Ω) =
∑
CN
i
=(xi−h/2,xi+h/2],
xi ∈ Crefj
vol(CNi ) |cNi − crefj |, (6.2)
where wN with its first component wN,(1) = cN is a numerical solution on N cells CN1 , . . . , C
N
N .
We compute numerical solutions on N cells for each method for
N ∈ {100, 200, 400, 800, 1000, 2000, 3000, 4000, 5000}
and plot N against E(N) in log-log scale in order to visualize the convergence of the method
experimentally. Due to the limitations of the comparison of numerical simulations with reference
solutions computed over very fine grids, the number of grid cells of the numerical solutions
should not be more than 10% of the number of cells of the reference. This is why we restrict
our numerical experiments to N = 5000.
Figure 6.2 indicates, that CND does not compute acceptable approximations. Though a first
order convergence can be observed, the relative error is larger than 11% even on grids with N =
5000 cells. However, STRANG seems to converge second order in space and produces accurate
solutions if about 1000 cells are used. Due to the instabilities on fine meshes, STRANG-CND
does not converge. The instabilities of the Strang-splitting, which employs the Crank-Nicolson
method for diffusion-terms, have been observed already in [TSL00]. The good performance of
the EXPLICIT method can be explained by the much smaller time steps it uses in order to be
stable. The large amount of time steps, however, increases the computational costs.
Figure 6.4 demonstrates, that the application of implicit methods for reaction-terms in STRANG
and IMEX3-ATC gives only negligible advantages over explicit reaction-terms on fine meshes,
which further decrease with decreasing cell widths. In Figure 6.3 the second order conver-
gence of IMEX3, ROS2 and ROS3 is demonstrated. All of them perform more accurately than
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Figure 6.1: Results of experiment I with parameterset P with Dc = 3.5 10−4.
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Figure 6.2: Experimental convergence plot of splitting and first order methods in experiment I in
log-log scale.
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Figure 6.3: Experimental convergence plot of different methods in experiment I in log-log scale
STRANG, whereas IMEX3 gives the best results. The computational costs for IMEX3 are also
less then the costs for ROS2 and ROS3, since the linearly implicit method handle reaction-terms
implicitly, which makes them solve systems of linear equations with less sparse matrices. Sur-
prisingly, the two stage Rosenbrock method gives a slightly better accuracy, than the three stage
Rosenbrock method. The IMEX2 method develops instabilities on fine meshes and therefore
does not converge. Though a slow convergence of the IMEX3 method with first order upwind
fluxes can be observed, it does not produce accurate approximations.
Figure 6.4 shows that ROS3-ATC produces slightly more accurate solutions than IMEX3-ATC,
but this advantage decreases with decreasing cell widths. Similarly we observe that the applica-
tion of implicit methods for reaction-terms in STRANG and IMEX3-ATC gives only negligible
advantages over explicit reaction-terms on fine meshes. Thus we state, that the advantage, which
we gain, if we use implicit methods to handle the reaction-terms, is not worth the additional
computational effort.
The influence of the CFL number on the accuracy of the IMEX3 method is much less than
to the GODUNOV method and for sufficiently large number of cells, the IMEX3 method with
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Figure 6.4: Relative differences of the errors |EM1(N) − EM2(N)|/EM1(N) of two methods M1 and
M2 in log-log scale. Square markers symbolize, that the error of the first mentioned method is less
than the error of the compared method. Whether reaction terms are treated implicitly or explicitly has
a minor, with grid size decreasing, impact on the error.
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Figure 6.5: The relative difference of IMEX3-ATC and IMEX3 with different Courant numbers in
loglog scale. The decreasing relative errors indicate that Courant numbers smaller than 0.49 do not
improve the method worthwhile.
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EOC Comperative CPU time discrete L1 error
CND 0.958 17.8 5.544 · 10−1
IMEX3-ATC-UPWIND1 0.691 48.7 5.414 · 10−1
STRANG 1.965 54.4 3.475 · 10−2
STRANG-IR 1.965 177.5 3.426 · 10−2
EXPLICIT 1.782 176.71 2.423 · 10−2
ROS3 2.044 246.39 2.337 · 10−2
ROS2 2.025 165.1 2.131 · 10−2
IMEX3-ATC 2.021 200.5 1.816 · 10−2
IMEX3-ATC-IR 2.034 18931.6 1.800 · 10−2
ROS3-ATC 2.080 10773.5 1.795 · 10−2
IMEX3 2.010 35.2 1.781 · 10−2
Table 6.1: Experimental orders of convergence, computation time and error of a sample approximation
for N = 2000 in experiment I
CFL=0.49 produces almost as accurate results as its counterpart with adaptive time step control,
see Figure 6.5.
Table 6.1 gives an overview of the experimental orders of convergence and the absolute discrete
L1-error of a sample solution with 2000 cells as well as its computation time. The experimental
order of convergence of a specified method is calculated based on its discrete L1-errors for
N1 = 2000 and N2 = 5000 cells
EOC =
log(E(N1))− log(E(N2))
log(N2)− log(N1) . (6.3)
6.2 Experiment II
In this experiment we investigate the performance of the methods in the case of a smooth
solution. Figure 6.6 exhibits the behavior of the solution of system (3.6) with homogeneous
Neumann boundary conditions on the domain Ω = (0, 10), initial conditions (6.1) and parameter
set P with an increased diffusion coefficient of the cancer cells,
Dc = 5.3 10
−3.
In order to estimate errors in this setting we make use of a reference solution wref, computed
with the IMEX3 method on N = 100 000 cells. Like before, we use a fixed Courant number
CFL = 0.49 and only compute solutions at the fixed time T = 50. Test approximations are
computed on the domain Ω = (0, 5) distributed into N cells with
N ∈ {100, 200, 400, 800, 1000, 2000, 3000, 4000},
and errors are calculated according to (6.2).
Figure 6.7 indicates that STRANG seems to be second order convergent in space. On the other
hand, STRANG-CND suffers from instabilities even on coarse grids and does not converge as
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Figure 6.6: Results of experiment II with parameterset P, where the diffusion coefficient of the cancer
cells is increased to Dc = 5.3 10
−3
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Figure 6.7: Experimental convergence plot of the considered methods in experiment II in log-log scale
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Figure 6.8: Experimental convergence plot of splitting methods in experiment I and experiment II in
log-log scale
EOC discrete L1 error
CND 0.935 1.980 · 10−2
IMEX3-ATC-UPWIND1 0.651 2.007 · 10−3
ROS2 1.906 9.853 · 10−5
ROS3 1.884 9.338 · 10−5
STRANG-IR 1.970 6.691 · 10−5
STRANG 1.974 6.178 · 10−5
IMEX3 1.882 5.167 · 10−5
IMEX3-ATC 1.935 5.066 · 10−5
Table 6.2: Experimental orders of convergence and error of a sample approximation for N = 2000 in
experiment II
in the first experiment. The forward Euler method is unstable in this case although the time
steps were limited according to the explicit discretization of diffusion. Similarly, instabilities
occur in the IMEX2 method case where no further time step limitation is needed.
ROS2, ROS3 and IMEX3 appear to be second order accurate, while IMEX3 approximates best
again. In this smooth case however, the Strang-splitting method performs similarly to IMEX3.
The three stage Rosenbrock method is advantageous over the two stage Rosenbrock method,
which reduces with the cell width. First order fluxes are capable to resolve the solution, as the
slow convergence of IMEX3-ATC-UPWIND1 in Figure 6.7 demonstrates.
We notice in Experiment II, that the EOCs of the various methods, are the same as in Exper-
iment I; there is though a significant drop in the actual errors. This can be seen in Figure 6.8
and in Table 6.2 by comparing the error convergence plots of the splitting methods. We also
notice the marginal positive influence of adaptive time step control and implicit treatment of
reaction-terms to the error.
Table 6.2 presents the EOC –computed according to (6.3)– using N1 = 2000 and N2 = 4000.
Again the discrete L1-error refers to a sample approximation computed on N = 2000 cells.
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Figure 6.9: A solution employing refinement of the cells according to the gradient of c.
Remark 6.1. In both, the larger and smaller diffusion case, the IMEX3 has produced approx-
imations that are among the most accurate that we have achieved. At the same time, the
computational cost of IMEX3 is short in comparison to other methods of the same accuracy.
Therefore we consider IMEX3 in the non-uniform adaptive mesh case.
6.3 Adaptive mesh refinement
Next, we investigate the benefits of adaptive mesh refinement by conducting experiment I again,
starting on a grid with 400 uniformly distibuted cells on Ω = (0, 5). For our experiments we
choose IMEX3 as time integration method and define nref = 1, ncoa = 3 constantly. Further,
we fix Lmax = 5. We compute the discrete L
1-errors over uniform and non-uniform grids using
the formula
E(tn) := |cref,n − cn|L1disc(Ω)(tn) =
∑
C
Nn
i
=(xn
i
−hn
i
/2,xn
i
+hn
i
/2]
xni ∈ Crefj
vol(CNni ) |cni − cref,nj |, (6.4)
where cref is the reference solution for the cancer cell density, computed by IMEX3 an a uniform
mesh with 50 000 cells, and c is the the solution obtained by the method whose error we want
to compute.
We consider the absolute gradient of c (5.14) with thresholds Cref = 55, Ccoa = 35, and
the estimated discretization error of the characteristic velocities (5.15) with thresholds Cref =
7 ·10−4, Ccoa = 4 ·10−4 as monitor functions for the adaptation of the mesh. We refer to Figure
6.9 for an impression of the numerical solution over and adaptively redefined grid, using the
gradient as monitor function.
Figure 6.10 displays the dynamics that we aim to capture with the adaptive mesh refinement
method that we employ. These involve moving, emerging, and merging of concentrations of the
cancer cell densities.
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(a) Travelling of the front concentration and emerging
of a second concentration for 0 ≤ t ≤ 23.
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(c) Further merging and emerging of concentrations while 50 ≤ t ≤ 60
Figure 6.10: Dynamics of the cancer cell concentration c for 0 ≤ t ≤ 60 in experiment I.
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Figure 6.11: A comparison of discrete L1-errors as functions in time of uniform and nonuniform
solutions for experiment I.
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Monitor
smooth
max{Ni, ti ≤ 35} ∑m, tm=35i=1 Nim max{Ni, ti ≤ 60} ∑n, tn=60i=1 Ninrefinement
|∇c| no 484 443.6 603 471.1
|∇c| yes 500 455.2 597 484.2
|P − P low| no 498 460.9 632 493.6
|P − P low| yes 481 449.6 648 478.5
Table 6.3: Maximal number of cells and average number of cells used by different refinement methods
for t ∈ [0, 35] and t ∈ [0, 60].
Figure 6.11 shows a visualization of the error (6.4) that the adaptive method, with the gradient
as monitor function. The error is smaller than the uniform solution on 600 cells up to the
emerging of the second concentration (around t = 23), albeit the refinement method uses less
than 500 cells. Employing discretization errors in monitor functions seems to be even more
beneficial since the error of the second refinement method is during almost all times t ∈ [0, 35]
less than the error of the uniform solution on 800 cells. Note that the second refinement method
does not use more than 500 cells. However, around t = 40, when concentrations of cancer cells
merge, this advantage vanishes and the gradient based refinement methods produces smaller
errors than the discretization based method. After t = 50, when the dynamics become more
complex, cf. Figure 6.10(c), both refinement methods perform even worse than the uniform
method on 400 cells.
Further, we propose a modification of both refinement methods that aims for a better regularized
structure of the grid. By “smoothly refined grid” we refer to a grid where the condition
|Lni − Lni+1| ≤ 1, i = 1, . . . Nn − 1, (6.5)
holds. To produce a smoothly refined grid we proceed as follows:
1. If a cell Cni which is to be refined has a neighbour C
n
j , j ∈ {i− 1, i+ 1} on a lower level
Lnj < L
n
i , we refine the neighbour C
n
j as well and iterate this strategy with C
n
j .
2. If a cell Cni that is marked for coarsening has a neighbour C
n
j on a higher level which is
not marked for coarsening, we do not coarsen Cni .
Figure 6.12 shows a further reduction of the discrete L1 errors when combining this strategy
with the h-refinement methods. The gradient controlled smooth refinement method produces
solutions close to those on uniform grids with 700 cells even for t > 40 while the discretization
error controled smooth refinement method performs comparably to an uniform solution on 800
cells for t ≤ 45. Reconstructing the first process of merging before t = 40 could be significantly
improved by employing smooth refinement however the error increases for later times. In the
case of the smooth refinement method controlled by the discretization error, the error becomes
as high as the error of its counterpart without smooth refinement. This happens at the end of
the observed time interval t = 60. However the gradient controlled smooth refinement method
performs better than the uniform method on 600 cells at t = 60.
6.4 A 2D experiment
We present results of a 2D-simulation, which has been conducted using IMEX3 on Ω = [−15, 15]2.
We employ uniform cells with grid size h = (0.05, 0.05)T , the parameter set P (3.10) and the
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(a) Refinement controled by the gradient of c.
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(b) Refinement controled by an estimation of the discretization error of the characteristic velocities.
Figure 6.12: Discrete L1-errors as functions in time of solutions for experiment I until t = 60. Benefits
of a smoother refinement.
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Figure 6.13: Initial conditions of the 2D experiment
following initial conditions,
y(x) =


4 + 0.7 sin(0.9x), x < 0,
7 sin(0.9x) + 0.008x3 + 4, 0 ≤ x ≤ 5,
5 + 0.7 sin(4.5) + 0.7 sin(0.9(x − 5)), x > 5,


c0(x) = 1{x2≥y(x1)}(x),
v0(x) = 1− c0(x),
u0(x) = 0.5c0(x),
p0(x) = 0.05c0(x),
m0(x) = 0,
(6.6)
for all x = (x1, x2)
T ∈ Ω. We display results in the window Ω¯ = [0, 5]2, which includes
100 × 100 grid cells, since this domain stays untouched by reflections, which are caused by the
homogeneous Neumann boundary conditions, while 0 ≤ t ≤ 200.
The initial conditions are visualized in Figure 6.13. Subsequently, the accumulated cancer
cells disseminate and degenerate the ECM. They travel in negative x2 direction, towards high
densities of vitronectin. Formations of heterogeneous patterns of cancer cells, occurs at areas
where the ECM has already degenerated by the propagating cancer cell front. No steady states
have appeared until T = 200. The corresponding results are shown in Figures 6.14, 6.15, and
6.16.
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Figure 6.14: 2D experiment at t = 50: degeneration of the ECM by a front of highly concentrated
cancer cells.
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Figure 6.15: 2D experiment at t = 100: formation of clusters in the cancer cell densities.
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Figure 6.16: 2D experiment at t = 200: formation of pattern in the cell and enzyme density structure.
Conclusion
We address in this work the formation cancer cell clusters and the dynamics of the cancer cell
invasion of the ECM. The model (3.6) we use, has been proposed in [CL05] and features the
role of the serine protease uPA.
We employ, in Section 5, a higher order finite volume method able to resolve the dynamics
of the solution of the system (3.6). Choosing the IMEX3 method for the time integration we
observe, in Section 6, an experimental second order of convergence. However, even this high
order method necessitates very fine discretization grids in order to produce accurate results.
In Section 6 we demonstrate that these computational costs can be reduced by employing mesh
refinement techniques, in particular h-refinement/cell bisection. We have noticed, with a series
of test scenarios, that the best results are obtained if a) the gradient of the cancer cells is used
as estimator function for the refinement/coarsening, and b) the grid is smoothly refined in the
sense that neighbouring cells have a difference in refinement level at most 1.
Analytically, we have studied in Section 4 a reduced chemotaxis-haptotaxis model with logistic
growth (4.1), which we have compared to the original system (3.6) in the following sense: as
in the case of the system (3.6) with parameter set P (3.10), so in the case of the system (4.1),
we have found parameters for which the perturbation modes grow due to chemotaxis. We have
thus, justified that the system (4.1) exhibits the same phenomena of merging and emerging
concentration. We have confirmed this behaviour also numerically.
We have proved L∞ bounds on the solutions of both systems and this allows us to sug-
gest/propose the smaller model (4.1), and the corresponding parameter set, as a test case
for the further development of mesh refinement techniques for the cancer invasion models. This
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test case can also be used for the extension of the mesh refinement technique that we have
employed here, to the two dimensional case; a task that we will take upon on a subsequent
paper.
As noted earlier, this is the first in a series of papers dealing with the invasion of cancer cells on
the ECM under different chemical interaction pathways. In our future study we concentrate on
one particular type of cancer and make our cancer-growth model more specific. One application
that we have in mind would be the breast cancer, which is of a solid nature and its growth
behaviour is quite well-understood and documented.
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